key: cord-0963314-x0nuv9bv
authors: Nishiyama, Keine; Takeda, Yohei; Maeki, Masatoshi; Ishida, Akihiko; Tani, Hirofumi; Shigemura, Koji; Hibara, Akihide; Yonezawa, Yutaka; Imai, Kunitoshi; Ogawa, Haruko; Tokeshi, Manabu
title: Rapid detection of anti-H5 avian influenza virus antibody by fluorescence polarization immunoassay using a portable fluorescence polarization analyzer
date: 2020-04-21
journal: Sens Actuators B Chem
DOI: 10.1016/j.snb.2020.128160
sha: e4b1f7dfbd39bdf1b29ec794463e030307d3c5f9
doc_id: 963314
cord_uid: x0nuv9bv

Abstract A rapid, facile and selective detection of anti-H5 subtype avian influenza virus (AIV) antibody in serum by fluorescence polarization immunoassay (FPIA) was achieved. A fragment of recombinant H5 subtype AIVhemagglutinin was produced and labeled with fluorescein to use it as a labeled antigen in FPIA. This labeled antigen was mixed with anti-AIV sera (H1–H16 subtypes) and FP of the mixture was measured using a portable FP analyzer on a microdevice. It was found that FP increased in proportion to the concentration of anti-H5 AIV antibody (serum) and was significantly higher than FP obtained with the other sera. The selective detection of anti-H5 subtype AIV antibody was confirmed. The required volume of original sample was 2 μL and analysis time was within 20 min. This detection system realizes an efficient on-site diagnosis and surveillance of AIV.

Highlights  FPIA for detection of anti-H5 subtype avian influenza virus (AIV) antibody was achieved. usually infects intestinal cells of aquatic birds and does not show pathogenicity; however, it can infect poultry and cause pathogenicity. [3] [4] The virus that causes a high mortality when poultry were infected is designated as a highly pathogenic avian influenza virus (HPAIV). To date, some H5 and H7 subtype

AIVs have been reported to be HPAIVs. [5] [6] [7] [8] H5N1 subtype HPAIV, which appeared after 1996, has been reported not only in poultry but also in humans. The mortality rate for humans infected with H5N1 is reported to exceed 50%. 9 If these HPAIVs have acquired human-to-human infectivity, the deaths of many persons world-wide due to a pandemic become a concern.

Rapid initial response for a suspected infection and continuous surveillance are indispensable to prevent poultry epidemics of HPAIV and further human threats. [10] [11] When a diagnosis is performed at the site of a disease outbreak, a rapid, simple and accurate antigen detection method is required. On the other hand, in the process from a disease occurrence to its cleanup and under a usual surveillance system, antibody detection to check for previous infections also plays an important role. Even in poultry that do not currently have the virus, the history of past infection can be determined by detecting antibodies. This is essential for investigating the routes of transmission of infectious diseases. As a recent example, antibody tests for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have received broad attention to prevent the spread of the novel coronavirus disease (COVID-19). [12] [13] Although some antibody tests, such as the agar gel immunodiffusion test, hemagglutination inhibition test and enzyme-linked immunosorbent assay are used for the detection of anti-AIV antibody, 14-18 these methods require complicated operations and a long reaction time. Therefore, it is impractical to use these methods outside the laboratory. If the method is developed that can rapidly and easily provide antibody test results outside the laboratory, field applications become possible and the surveillance system using the antibody test can be significantly strengthened.

Fluorescence polarization immunoassay (FPIA) is widely used in various fields and it has the degree of polarization (P) as a parameter. [19] [20] Advantages of FPIA compared to other immunoassays are the simplicity and rapidity of its procedures and the short measurement time. FPIA does not need a washing step and the reaction is completed by simply mixing the reagents together. In this study, we developed a system that selectively detected anti-H5 AIV serum by measuring P value of the mixture of an anti-AIV serum and fluorescein-labeled H5 subtype hemagglutinin (HA) glycoprotein using a newly designed microdevice based on our previously developed microdevice with a portable FP J o u r n a l P r e -p r o o f 6 analyzer 21-23 ( Fig. 1(a) ) . Besides being portable, our FP analyzer is low cost and has high throughput, and these features make it possible to conduct FPIA outside the laboratory. All procedures from sampling to obtaining measurement results can be completed on-site, and that contributes to a significant increase in efficiency of diagnosis and surveillance. Kingdom).

As an antigen for the FPIA, recombinant H5 subtype AIV HA (H5-rHA) was produced using the bacterial expression system as we previously described 25 J o u r n a l P r e -p r o o f isopropyl--d-thiogalactopyranoside was used to induce the expression of the partial HA gene. The protein extracted from the bacteria was purified using nickel-nitrilotriacetic acid (Ni-NTA) agarose.

The recombinant protein obtained was concentrated using an ultrafiltration membrane, and then dialyzed against PBS. The recombinant protein was identified by Western blotting using anti-H5 mouse serum, and its concentration was measured by the Micro BCA Protein Assay Kit. The resultant H5-rHA was labeled using the Lightning-Link Fluorescein Conjugation Kit.

The goat antisera against H1-H15 subtypes and the chicken antiserum against H16 subtype AIV were kindly provided by Dr. Yoshihiro Sakoda (Hokkaido University, Sapporo, Japan). The immunogen of each serum is shown in Table 1 .

The basic PDMS microfluidic device was fabricated using the standard soft lithography technique, as described in our previous work. 24 Briefly, the mold was fabricated from negative J o u r n a l P r e -p r o o f photoresist SU-8 3050 and a silicon wafer (Sumco Co., Tokyo, Japan). The negative photoresist SU-8 3050 was spin-coated onto a silicon wafer. The PDMS prepolymer with black silicon rubber was poured onto the mold and cured. The cured PDMS was pasted on a glass slide. Figs. 1 (b) and (c) show a photograph and a schematic drawing of the microfluidic device. We designed the microfluidic device for this experiment based on the basic device. The microdevice had nine channels arranged in the field of view of the portable FP analyzer, and nine samples could be measured at one time. The width of the channel was 200 μm and the depth is 900 μm. The depth of the microfluidic device was significantly different from our previous device. By employing a channel having a high aspect ratio, it was possible to increase the fluorescence intensity per unit area and reduce specific surface area. These features contributed to highly sensitive measurement (Fig. S1 ). The numbers in Fig. 1 (c) denote inlets and outlets, and the solution was injected into the inlet with a pipet (Eppendorf, Hamburg, Germany).

We used our previously developed portable FP analyzer for FP measurement. 24 

Anti-AIV serum diluted in a prescribed ratio and 640 ng/mL fluorescein-labeled H5-rHA were mixed at a volume ratio of 1:1. The mixture was incubated at room temperature for 15 min. Then, 20

μL of the mixture was injected into the microfluidic device and P value was measured with our portable FP analyzer. The FP analyzer acquired P images in the detection area. The P value measured was determined by reading out the luminance on the P image in the detection area of the microdevice. As shown in Fig. 1 (c) , nine channels were placed within the detection area. Therefore, nine samples could be measured simultaneously.

In the FPIA measurement, P value is expressed by the following equation: where I‖ and I are the fluorescence intensities of the vertical and horizontal components of the emitted light, respectively. A free fluorescence-labeled antigen emits random fluorescence when excited by polarized light and it gives a low P value. When a fluorescence-labeled antigen is bound to an antibody, P value is high due to the much slower Brownian motion of the antibody-H5-rHA complex. [19] [20] Fig. 2 shows the schematic illustration of FPIA in this work. When anti-H5 antibody in serum binds to a fluorescein-labeled H5-rHA, P value becomes high. Therefore, anti-H5 AIV serum containing a large amount of anti-H5 HA antibodies shows a higher P value than that of the antibody-negative serum. In this work, we used the fragment of H5-rHA (not whole H5-rHA) as an antigen to improve the sensitivity. Using a smaller fluorescence-labeled antigen reduces P value of the blank sample. Fig. 3 shows an example of a P image obtained using our portable FP analyzer. Samples used were a mixture Our microdevice required 20 μL of solution per one channel. Since serum and fluorescein-labeled H5-rHA were mixed at a volume ratio of 1 : 1, the required serum volume for an analysis was 10 μL.

When a serum with 5-fold dilution was used for the analysis, the required volume of the original serum J o u r n a l P r e -p r o o f was 2 μL. It would be sufficiently small for application to on-site diagnosis and surveillance.

Therefore, 5-fold dilution of antiserum was used in the next experiment.

Next, we verified whether our system could selectively detect anti-H5 AIV serum in anti-H1-H16 AIV sera. Fig. 6 shows the P value obtained with anti-H1-H16 sera. The cutoff value for positive anti-H5 AIV antibody was defined as the average + 3SDs. Anti-H5 serum showed the highest P value among all anti-AIV sera and all other antisera except where anti-H5 was below the cut-off value.

Therefore, we showed that there was no false positive result with other anti-subtype sera. The incubation time was 15 min (total analysis time was within 20 min), which was significantly shorter than the time needed by conventional ELISA-based devices. These findings showed that our FPIA system selectively detected the anti-H5 AIV serum.

We developed the rapid and easy-to-use system for the FPIA detection of anti-H5 AIV serum.

Analysis time was within 20 min and required sample volume was only 2 μL. Our portable FP analyzer with the microfluidic device makes it possible to conduct on-site analysis. Further study on blocking of protein adsorption to PDMS devices may lead to improved sensitivity and selectivity of a detection. Table   Table 1 Immunogens of goat anti-AIV sera. 

Cumulative number of confirmed human cases of avian influenza A(H5N1) reported to WHO

Keine Nishiyama is currently a Ph.D. candidate at Hokkaido University; he obtained his MS degree in Hokkaido University, Japan in 2016. His current research interests are micro-and nano-system for

Manabu Tokeshi is a Professor in the Division of Applied Chemistry, Hokkaido University. He received his PhD degree from Kyushu University in 1997. His research interests are in the development of micro-and nano-systems for chemical

This work was supported by the JST-SENTAN program JPMJSN16A2. This work was partially supported by Hokkaido University Research and Education Center for Robust Agriculture, Forestry, and Fisheries Industry. This research and development work was also supported by the MEXT Doctoral program for Data-Related InnoVation Expert Hokkaido University (D-DRIVE-HU) program.We would like to thank Dr. Toshihiro Ito, Tottori University, Japan, who kindly provided us with the H5N3 AIV; and Dr. Yoshihiro Sakoda, Hokkaido University, Japan, who kindly provided us with the anti-H1-H16 sera.J o u r n a l P r e -p r o o f